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Since its introduction in the mid 1990s mechanical intra-abdominal
morcellation of uterine tissue at the time of laparoscopic surgery is
commonly performed to facilitate the removal of large uteri or
leiomyomas through small incisions. However, with mechanical
morcellation there are reported risks of metastasizing leiomyosarcoma,
uterine cancer, introduction of complications from retained fragments
of myomas, and endometriosis (Lieng et al., 2006; Sepilian and Della
Badia, 2003). Here we present a case that further illustrates the potential
malignant risk of uterine morcellation and the uncertainty regarding the
primary site of tumor origin.
Case report
A perimenopausal 56 year old nulliparous woman underwent
supracervical laparoscopic hysterectomy and bilateral salping-
oophorectomy for pelvic pain, menorrhagia, and large uterine
leiomyomas. She had no history of abnormal Pap smears and a preoper-
ative Pap smear was normal. Her family history was negative for any
known gynecologic, breast, or gastrointestinal malignancies. Preopera-
tive chest radiograph and endometrial biopsy were not obtained. Due⁎ Corresponding author at: Duke University Medical Center Box 3079, Durham, NC
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tion of the procedure. The specimen was sent for frozen section and
was negative for malignancy. Intraoperative ﬁndings were signiﬁcant
for an 18–20 week size uterus weighing 1518 g. Prolonged mechanical
morcellation with a ROTOCUT G1 morcellator (Karl Storz, Germany)
was required to remove the uterus and a small amount of superﬁcial
endometriosis in the pelvis was seen and cauterized. The fallopian
tubes and ovarieswere removed intact in an endoscopic bag. The uterus
was not morcellated in a bag, and the fragments were subsequently
collected fromwithin the abdomen, andwithdrawn froma laparoscopic
port. Final pathology on six uterine fragments revealedweakly prolifer-
ative phase endometriumwithout atypia, adenomyosis and leiomyoma
in the uterus. The ovaries showed fragments of benign ovarian paren-
chyma and patchy endosalpingiosis. No malignancy was identiﬁed in
any specimen.
The patient's initial recovery was unremarkable until 14 months
post-operatively when she presented with left lower quadrant pain
and persistent cough with shortness of breath. Examination revealed a
ﬁrm palpable abdominal mass at the left lower quadrant and a ﬂeshy
lesion at the apex of the vagina. The cervix could not be identiﬁed.
PET–CT revealed multiple hypermetabolic masses in the pelvis
(Fig. 1), abdomen, and chest (Fig. 2) concerning for metastatic disease.
A core needle biopsy from the 9 cm left pelvic mass revealed poorly
differentiated malignant neoplasm of epithelioid cells with hyper-
chromatic nuclei in a background of necrosis. Immunohistochemical
stains showed tumor cells positive for cytokeratin, vimentin, and
CD138. The tumor cells were negative for SMA, EMA, ER, TLE1, HNB45,
desmin, myogenin, CD17, BCL2, inhibin, MDN2, CD4, CA125, WT-1,
CD45, calretinin, DOG-1, p16, CEA, CK 20, HPV, and CD99. The vaginal
biopsy showed grade 3 endometrioid adenocarcinoma. Pathology
re-review of the supracervical hysterectomy and bilateral salpingo-
oophorectomy specimens showed no evidence of malignancy. The
differential diagnosis included recurrent uterine cancer (unrecognized
at time of morcellation) versus primary peritoneal carcinoma that
developed from endometriosis.
The patient was treated with intravenous carboplatin AUC 6 and
paclitaxel 175 mg/m2 every 21 days and had a partial response after
two cycles. She completed six cycles of therapy, but unfortunately de-
veloped rapidly progressive disease. One month after her sixth cycle
of chemotherapy, she presented with a complex ﬁstula involving
the pelvic tumor, abdominal wall, and sigmoid colon. She underwent
a diverting loop colostomy. She strongly desired further therapy and
received one cycle of doxorubicin 60 mg/m2. After admission for
Fig. 1. Fused PET/CT coronal image of the large hypermetabolic pelvic mass.
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tion her care to hospice and died of her disease two months later.
Discussion
Our case illustrates the potential risk of metastatic adenocarcinoma
diagnosed after hysterectomywith uterinemorcellation. Deﬁnite causal
relationship of metastatic disease as a result of morcellation cannot be
proven; however, in the setting of an unknown cancer diagnosis at
time of morcellation, subsequent widespread dissemination in the
pelvis may result. Others have reported metastatic leiomyosarcoma,
disseminated endometriosis (Sepilian and Della Badia, 2003), pelvic
atypical endometrial hyperplasia (Kill et al., 2011), and uterine cancer
after uterine morcellation (Einstein et al., 2008). In the largest case–
control study to date, morcellation of unsuspected leiomyosarcoma
was associated with an increased risk of peritoneal recurrence and
worse overall survival (Park et al., 2011).Fig. 2. Fused PET/CT sagittal section showing two hypermetabolic lung nodules (marked
with arrows).In our case the primary site ofmalignancywas uncertain. A plausible
source could be that she had an unrecognizedmalignancy at the time of
initial hysterectomy. Schneider et al. reported a case of undifferentiated
adenocarcinoma ﬁve months after laparoscopic supracervical hysterec-
tomy. The patient had undergone a macromorcellation supracervical
hysterectomy and vaginal intrafascial cylindriform enucleation of the
cervix and corpus uteri. In this procedure, the ﬁrst core is performed
vaginally to allow for a contiguous punched out specimen containing
the cervix, endocervix, endometrium, and myometrium to optimize
pathological evaluation. However, even with this additional step, initial
pathology review showed no evidence of malignancy. When she was
diagnosed with undifferentiated adenocarcinoma of a pelvic mass,
retrospective review of the initial morcellated hysterectomy revealed
clusters of malignant cells attached to the endocervical epithelium.
However, the deﬁnite source of the malignant tissue could not be iden-
tiﬁed (Schneider, 1997). Although our case did not show evidence of
malignancy at the time of hysterectomy, it is plausible that the malig-
nancy was unrecognized. Two considerable diagnostic challenges
were the large uterine size and the morcellation. Rivard and colleagues
demonstrated the challenges of accurate detection of endometrial
cancer in morcellated specimens. In this prospective case series, after
standard processing and diagnosis of endometrial disease from intact
uteri, all specimenswere thenmorcellated. A single pathologist blinded
to the initial diagnosis reviewed each morcellated specimen. The diag-
nosis of malignancy was missed in 4 of 5 specimens of known cancer
(Rivard et al., 2012).
Another possible source of themalignancy is themalignant trans-
formation of retained endometrial tissue or endometriosis after
morcellation. Our patient had endometriosis involving the serosa of
the uterus. Interestingly, Schuster et al. compared morcellated to
non-morcellated hysterectomy cases and found no signiﬁcant difference
in outcomes in women that had endometriosis diagnosed at the time of
hysterectomy. In this case–control study of 464 cases there was no dif-
ference in the incidence of new onset endometriosis between women
undergoing a supracervical hysterectomy with uterine morcellation
versus those women undergoing traditional vaginal or abdominal
hysterectomywithout morcellation (Schuster et al., 2012). However,
reoperation for those with endometriosis in the morcellation group
did show persistent or recurrent endometriosis. Endometriosis is asso-
ciated with an increased risk of endometrioid invasive ovarian cancer
(Pearce et al., 2012). Further investigation is needed to understand
the risk factors of malignant transformation of endometriosis.
Minimally invasive surgery (MIS) has well documented beneﬁts
and uterine morcellation plays an important role in facilitating less
invasive procedures for large uteri. However, the potential morbidity
frommechanical uterine morcellationmust be recognized. Appropriate
pre-operative screening to rule out endometrial carcinoma in asymp-
tomatic women prior to morcellation is challenging. Of the 708
women undergoing hysterectomy for pelvic organ prolapse, the inci-
dence of endometrial cancer was only 0.6% (Ramm et al., 2012). Fur-
thermore, 4 out of the ﬁve cancers detected in this study had normal
preoperative screening with endometrial biopsy, ultrasound, or both
tests. Thus, routine preoperative evaluation of asymptomatic women
did not yield additional beneﬁt and may be cost prohibitive (Ramm
et al., 2012). Intraoperative attention to removal of all fragments of
tissue at time of morcellation is imperative. In addition alternative
morcellation techniques such as vaginal morcellation in a sterile
bag, controlled abdominal port morcellation in a sterile bag, or
minilaparotomy after MIS to remove the specimen intact to avoid
dissemination of endometrial tissue into the abdominal cavity
should be considered. Potential strategies need to be developed to
improve accuracy of pathologic evaluation of morcellated specimens.
Becausemalignant complications frommorcellation are rare, conclusive
statements cannot be made on the causality of morcellation to subse-
quent development of malignancy. Nevertheless, given the increasing
case reports of poor outcomes after morcellation, further investigation
21T. Turner et al. / Gynecologic Oncology Reports 5 (2013) 19–21in developing risk stratiﬁcation to identify women who should avoid a
morcellation procedure should be considered.
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